Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
AI Chip Stocks Surge on Tech Spending Plans; CPI and Nvidia Earnings Loom
Nvidia and AMD rallied sharply Friday as the Dow closed above 50,000, fueled by Big Tech's massive AI capital expenditure plans. The focus now shifts to inflation data and Nvidia's upcoming earnings.
Caterpillar Powers Dow Past 50,000 as Investors Shift to Industrials
Caterpillar surged 7% to $726.20, driving the Dow Jones Industrial Average above the 50,000 milestone. Investors rotated capital from technology into industrial stocks ahead of key U.S. economic data releases next week.
P&G Shares Gain as Investors Eye Defensive Rotation, Upcoming Economic Data
Procter & Gamble stock rose 0.37% to $159.17 amid a shift toward defensive, dividend-paying equities. Key U.S. jobs and inflation reports are due next week, alongside P&G's dividend payment.
AbbVie Gains on Moody's Credit Upgrade, Focus Shifts to Immunology Portfolio
AbbVie shares rose 2% to $223.43 after Moody's upgraded its credit rating to A2 with a stable outlook. Investors now watch demand and pricing for Skyrizi and Rinvoq amid Humira competition.
SK hynix Shares Dip Amid Tech Sell-Off, Dividend Dates Set
SK hynix closed at 839,000 won, down 0.36%, as the KOSPI fell 1.4% to end a six-week rally. The company announced a 1,875 won per share dividend with key dates in late February.
Roche's MS Drug Trial Results Spark Investor Scrutiny Ahead of Key Presentation
Roche's experimental multiple sclerosis drug fenebrutinib met its primary endpoint in a late-stage study but showed higher liver enzyme elevations and fatalities versus Ocrevus. Investors await Monday's detailed data webcast.
Roche's MS Drug Trial Results Set Stage for Monday Investor Scrutiny
Roche's fenebrutinib met its primary endpoint in a late-stage PPMS trial, showing non-inferiority to Ocrevus but with higher liver enzyme elevations and fatal cases. Shares closed at 356.40 Swiss francs, down 0.6%.
Bank of America Rises with Broader Rally, Eyes on Key Economic Data
Bank of America shares advanced 2.9% to $56.53 on Friday, joining a market surge that pushed the Dow above 50,000. Investors now await delayed U.S. jobs and inflation figures, which could influence interest rate expectations.
